Lyme vaccine passes safety check in 3,500 kids
NCT ID NCT05634811
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new Lyme disease vaccine (VLA15) is safe for healthy children ages 5 to 17. Over 3,500 kids received either the vaccine or a placebo (saltwater shot) and were monitored for about 2 years. The main goal was to check for side effects like pain, redness, fever, or other reactions after each of the 4 shots. The study has been completed, and the results will help decide if the vaccine can be used to prevent Lyme disease in children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
3,547 people
The number who actually took part.
- Started
-
Dec 2022
- Finished
-
Jul 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy participants at enrollment who are determined to be eligible for inclusion in the study. Participants with preexisting chronic medical conditions determined to be stable may be included. * Participants and/or participants' parent(s)/guardian who are willing and able to comply with all scheduled visits, study procedures and lifestyle considerations for the duration of the study. Exclusion Criteria: * Female participants that are pregnant, breastfeeding, or have a positive urine pregnancy test at Visit 1. Sexually active females and fertile males unwilling to use contraception as per protocol. * Any contraindication to vaccination or vaccine components, including previous anaphylactic reaction to any vaccine or vaccine-related components. * Any diagnosis of Lyme disease within the past 3 months. * Any history of Lyme arthritis, carditis, neuroborreliosis, or other disseminated Lyme Disease (LD), regardless of when diagnosed. * Known tick bite within the past 4 weeks. * Congenital or acquired immunodeficiency or other conditions or treatments associated with immunosuppression that would inhibit the ability to mount an immune response to a vaccine. * Other medical, psychiatric condition, active suicidal ideation/behavior or lab abnormality which increases risk of study participation or, in investigator's judgment is inappropriate for the study. * Receipt of a previous vaccination for LD. * Treatment for LD in the 3 months prior to study intervention administration. * Receipt of blood/plasma products or immunoglobulins within 6 months before study intervention administration through conclusion of the study. * Receipt of systemic corticosteroids for ≥14 days within 28 days before study intervention administration. Inhaled/nebulized, intra-articular, intrabursal, or topical corticosteroids are permitted. * Receipt of chronic systemic treatment with other known immunosuppressant medications, or radiotherapy, within 6 months before study intervention administration. * Current use of any prohibited concomitant medication(s) or participants unwilling/unable to use a permitted concomitant medication(s). * Participation in other studies involving investigational drugs/vaccines/devices within 28 days prior to study entry and/or during study participation (observational studies are acceptable). * Investigator site staff, sponsor/sponsor delegates directly involved in the conduct of the study and their family members; site staff supervised by the investigator and their family members.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lyme disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMR Clinical
El Dorado, Kansas, 67042, United States
-
AMR Clinical
Wichita, Kansas, 67207, United States
-
ASR, LLC
Boise, Idaho, 83702, United States
-
Advanced Specialty Care
Commack, New York, 11725, United States
-
Advantage Clinical Trials
The Bronx, New York, 10467, United States
-
All Children Pediatrics
Louisville, Kentucky, 40243, United States
-
Allegheny Health and Wellness Pavilion
Erie, Pennsylvania, 16506, United States
-
Apex Research Group LLC
Fair Oaks, California, 95628, United States
-
Benchmark Research
Austin, Texas, 78705, United States
-
Benchmark Research
Fort Worth, Texas, 76135, United States
-
Bio-Medical Research LLC
Miami, Florida, 33144, United States
-
Buffalo Clinical and Translational Research Center
Buffalo, New York, 14203, United States
-
C & R Research Services USA
Houston, Texas, 77022, United States
-
Central Erie Primary Care
Erie, Pennsylvania, 16508, United States
-
Centricity Research Columbus Ohio Multispecialty
Columbus, Ohio, 43213, United States
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
-
Clinical Research Institute
Minneapolis, Minnesota, 55402, United States
-
Clinical Research Partners, LLC
Richmond, Virginia, 23226, United States
-
Clinical Research Prime
Idaho Falls, Idaho, 83404, United States
-
Clinical Research Prime Rexburg
Rexburg, Idaho, 83440, United States
-
Coast Clinical Research, LLC
Bellflower, California, 90706, United States
-
Coastal Carolina Research Center
North Charleston, South Carolina, 29405, United States
-
DM Clinical Research - Kool Kids Pediatrics
Houston, Texas, 77065, United States
-
DiGiovanna Institute for Medical Education & Research
North Massapequa, New York, 11758, United States
-
ForCare Clinical Research
Tampa, Florida, 33613, United States
-
Frontier Clinical research
Kingwood, West Virginia, 26537, United States
-
GCP Research, Global Clinical professionals
St. Petersburg, Florida, 33705, United States
-
Great Lakes Research Institute
Southfield, Michigan, 48075, United States
-
Hassman Research Institute
Marlton, New Jersey, 08053, United States
-
IMA Clinical Research Warren
Warren Township, New Jersey, 07059, United States
-
Kentucky Pediatric/ Adult Research
Bardstown, Kentucky, 40004, United States
-
Lakeview Clinical Research
Guntersville, Alabama, 35976, United States
-
MD Medical Research
Oxon Hill, Maryland, 20745, United States
-
MOORE Clinical Research, Inc. d/b/a TrueBlue Clinical Research
Tampa, Florida, 33609, United States
-
Michigan Center of Medical Research (MICHMER)
Bingham Farms, Michigan, 48025, United States
-
NYU Langone Hospital - Long Island
Mineola, New York, 11501, United States
-
New England Research Associates
Bridgeport, Connecticut, 06606, United States
-
Northeast Clinical Trials Group
Scranton, Pennsylvania, 18510, United States
-
Pediatric Research of Charlottesville, LLC
Charlottesville, Virginia, 22902, United States
-
Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18)
Pittsburgh, Pennsylvania, 15236, United States
-
Preston Healthcare Services
Kingwood, West Virginia, 26537, United States
-
Prime Global Research
The Bronx, New York, 10456, United States
-
Research Your Health
Plano, Texas, 75093, United States
-
Rochester Clinical Research, LLC
Rochester, New York, 14609, United States
-
Rutgers University
New Brunswick, New Jersey, 08901, United States
-
Sisu BHR
Springfield, Massachusetts, 01103, United States
-
Smith Allergy & Asthma Specialists
Horseheads, New York, 14845, United States
-
Smith Allergy and Asthma Specialists
Cortland, New York, 13045, United States
-
Southampton Hospital
Hampton Bays, New York, 11946, United States
-
Stamford Therapeutics Consortium
Stamford, Connecticut, 06905, United States
-
Stony Brook Medicine Clinical Research Center
East Setauket, New York, 11733, United States
-
Stony Brook University
Stony Brook, New York, 11794, United States
-
Sun Research Institute
San Antonio, Texas, 78215, United States
-
Tekton Research, LLC.
Chamblee, Georgia, 30341, United States
-
Texas Health Resources
Fort Worth, Texas, 76135, United States
-
UAB Child Health Research Unit (CHRU)
Birmingham, Alabama, 35233, United States
-
University of Alabama at Birmingham - School of Medicine
Birmingham, Alabama, 35233, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
Upstate Global Health Institute
East Syracuse, New York, 13057, United States
-
Velocity Clinical Research, Binghamton
Binghamton, New York, 13905, United States
-
Velocity Clinical Research, Omaha
Omaha, Nebraska, 68134, United States
-
Velocity Clinical Research, Salt Lake City
West Jordan, Utah, 84088, United States
-
Velocity Clinical Research, Vestal
Vestal, New York, 13850, United States
-
Vida Clinical Studies, LLC
Dearborn Heights, Michigan, 48127, United States
-
White Oak Pediatrics
Silver Spring, Maryland, 20904, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell tracking could sharpen lyme disease diagnosis
- Lyme disease and parenthood: a hidden struggle revealed
- Lyme disease in pregnancy: new study tracks baby brain development
- New blood test aims to spot lyme disease in kids faster and more accurately
- New mRNA vaccine could stop lyme disease in its tracks
- Could a single pill stop lyme disease before it starts?